Summaries of health policy coverage from major news organizations
Pfizer to Offer Free Diflucan to AIDS Patients in Six African Nations
Pfizer Inc. on Saturday announced it will provide its antifungal medication Diflucan free of charge to people with AIDS in six African nations, Reuters reports (Reuters, 12/1). Pfizer will sign memoranda of understanding with Botswana, Lesotho, Malawi, Uganda, Namibia and Swaziland to launch Diflucan programs in early 2002 (South African Press Association, 12/1). Diflucan treats cryptococcal meningitis and esophageal candidiasis, two infections that are common among people with AIDS (Reuters, 12/1). Pfizer currently operates a Diflucan program in South Africa, where citizens can receive the medicine free of charge through the country's public health system (Kaiser Daily HIV/AIDS Report, 12/4/2000). The program also helps train health workers (Reuters, 12/1). Pfizer spokesperson Imraan Munshi said that the company looks forward to providing additional training, education and treatments as the Diflucan program expands into other African nations (South African Press Association, 12/1).
This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.